{"id":"W1978580856","doi":"10.1200/jco.2006.10.2871","title":"Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Sorafenib; Internal medicine; Nasopharyngeal carcinoma; Oncology; Head and neck squamous-cell carcinoma; Carcinoma; Adverse effect; Chemotherapy; Progressive disease; Head and neck cancer; Response Evaluation Criteria in Solid Tumors; Radiation therapy; Stage (stratigraphy); Gastroenterology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002288088,0.000152735,0.002035166,0.0001307811,0.0000453399,0.000001617694,0.0001333559,0.0001394468,0.00004014057],"category_scores_gemma":[0.001968873,0.00006935936,0.0002363576,0.0002443449,0.0003537799,0.00005583305,0.00008117316,0.0006657048,2.955931e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009869877,"about_ca_system_score_gemma":0.001733925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004812491,"about_ca_topic_score_gemma":0.0005350548,"domain_scores_codex":[0.9961919,0.0003193163,0.002621578,0.0001663879,0.0004505434,0.0002502353],"domain_scores_gemma":[0.995325,0.002071635,0.001792748,0.0001753305,0.0004012551,0.0002340777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6055195,0.02016822,0.3081369,0.0001791015,0.0001013122,0.0003581908,0.0007021836,7.358377e-7,0.00003507043,0.000004864243,0.0005978827,0.06419603],"study_design_scores_gemma":[0.2802993,0.2467396,0.4708715,0.0001157371,0.000340719,0.00003218698,0.0001559391,0.000007184489,0.0002186949,0.000008282682,0.0011565,0.00005443787],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965938,0.0005824327,0.000004814486,0.0008609442,0.000947885,0.0006090617,0.00001131496,0.000001537157,0.0003882184],"genre_scores_gemma":[0.998472,0.00008189354,0.0006879212,0.0003487257,0.0003099936,0.000002907707,9.618162e-7,0.00001219277,0.00008345653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3252203,"threshold_uncertainty_score":0.3075909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.12490601408766,"score_gpt":0.4508927971275671,"score_spread":0.3259867830399071,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}